Literature DB >> 8141765

Unmethylated thyroglobulin promoter may be repressed by methylation of flanking DNA sequences.

B Pichon1, C Christophe-Hobertus, G Vassart, D Christophe.   

Abstract

The thyroglobulin gene, like many other tissue-specific genes, appears to be specifically less methylated in the differentiated cell type where it is transcribed. The thyroglobulin gene promoter elements themselves are highly CG-deficient and do not contain any HpaII/MspI sites. In this study, using DNA constructs that were methylated in vitro with HpaII or MspI methylases, we show that DNA methylation of vector sequences is sufficient to repress the activity of the thyroglobulin gene promoter in transient transfection experiments. Reporter-gene expression from a plasmid containing only the proximal thyroglobulin gene promoter is sensitive to DNA methylation even in fully differentiated thyrocytes. Transcription from methylated plasmids containing the thyroglobulin gene enhancer and proximal promoter is also clearly reduced when the transfected cells are maintained under less-differentiated conditions. These results indicate that DNA methylation can influence, from a distance, the activity of an unmodified promoter. Our results also agree with the view that loss of DNA methylation does not constitute a prerequisite for thyroglobulin gene expression in differentiated thyrocytes, where the thyroglobulin gene enhancer and promoter are activated. However, the production of thyroglobulin transcripts could be severely impaired when this activation is not maximal, as is the case in less-differentiated cells or when the enhancer element is lacking. We suggest that DNA methylation helps to maintain the thyroglobulin gene in an inactive state unless all of the conditions required for its expression are fulfilled, and that the thyroid-specific demethylation events are a consequence of the activation state of the gene.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8141765      PMCID: PMC1137892          DOI: 10.1042/bj2980537

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  19 in total

1.  Identification of a transcriptional enhancer upstream from the bovine thyroglobulin gene.

Authors:  C Christophe-Hobertus; A Donda; F Javaux; G Vassart; D Christophe
Journal:  Mol Cell Endocrinol       Date:  1992-10       Impact factor: 4.102

2.  Identification of a cAMP-responsive region in thyroglobulin gene promoter.

Authors:  D Christophe; C Gérard; G Juvenal; A Bacolla; E Teugels; C Ledent; C Christophe-Hobertus; J E Dumont; G Vassart
Journal:  Mol Cell Endocrinol       Date:  1989-06       Impact factor: 4.102

3.  Cytosine methylation in CTF and Sp1 recognition sites of an HSV tk promoter: effects on transcription in vivo and on factor binding in vitro.

Authors:  J Ben-Hattar; P Beard; J Jiricny
Journal:  Nucleic Acids Res       Date:  1989-12-25       Impact factor: 16.971

4.  Methylation and expression of the human thyroglobulin gene.

Authors:  F Libert; G Vassart; D Christophe
Journal:  Biochem Biophys Res Commun       Date:  1986-02-13       Impact factor: 3.575

5.  Muscle-specific activation of a methylated chimeric actin gene.

Authors:  J Yisraeli; R S Adelstein; D Melloul; U Nudel; D Yaffe; H Cedar
Journal:  Cell       Date:  1986-08-01       Impact factor: 41.582

Review 6.  DNA methylation and gene activity.

Authors:  H Cedar
Journal:  Cell       Date:  1988-04-08       Impact factor: 41.582

Review 7.  DNA methylation. The effect of minor bases on DNA-protein interactions.

Authors:  R L Adams
Journal:  Biochem J       Date:  1990-01-15       Impact factor: 3.857

Review 8.  DNA methylation patterns. Formation and function.

Authors:  A Razin; M Szyf
Journal:  Biochim Biophys Acta       Date:  1984-09-10

9.  Tissue-specific expression and methylation of a thyroglobulin-chloramphenicol acetyltransferase fusion gene in transgenic mice.

Authors:  C Ledent; M Parmentier; G Vassart
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

10.  Control of thyroperoxidase and thyroglobulin transcription by cAMP: evidence for distinct regulatory mechanisms.

Authors:  C M Gérard; A Lefort; D Christophe; F Libert; J Van Sande; J E Dumont; G Vassart
Journal:  Mol Endocrinol       Date:  1989-12
View more
  4 in total

1.  Multiple factors regulating the expression of human thromboxane synthase gene.

Authors:  K D Lee; S J Baek; R F Shen
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

2.  Peptide receptor radionuclide therapy of treatment-refractory metastatic thyroid cancer using (90)Yttrium and (177)Lutetium labeled somatostatin analogs: toxicity, response and survival analysis.

Authors:  Hendra Budiawan; Ali Salavati; Harshad R Kulkarni; Richard P Baum
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-12-15

3.  Global DNA methylation evaluation: potential complementary marker in differential diagnosis of thyroid neoplasia.

Authors:  Bogdan Galusca; Jean Marc Dumollard; Sandrine Lassandre; Alain Niveleau; Jean Michel Prades; Bruno Estour; Michel Peoc'h
Journal:  Virchows Arch       Date:  2005-05-13       Impact factor: 4.064

4.  Site-specific methylation of the rat prolactin and growth hormone promoters correlates with gene expression.

Authors:  V Ngô; D Gourdji; J N Laverrière
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.